Wenstrup Richard 4
4 · Oxford Immunotec Global PLC · Filed Jul 26, 2017
Insider Transaction Report
Form 4
Wenstrup Richard
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2017-07-24+18,622→ 18,622 total - Award
Share Option (Right to Buy)
2017-07-24+61,920→ 61,920 totalExercise: $16.11Exp: 2027-07-24→ Ordinary Shares (61,920 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from August 1, 2018 through August 1, 2021.